STREAMING NOW: Watch Now

FDA approves preventive migraine treatment

Migraine sufferers across the United States have their eyes on a newly approved drug that's offering hope for reducing the frequency of monthly migraine attacks.

Migraine sufferers across the United States have their eyes on a newly approved drug that's offering hope for reducing the frequency of monthly migraine attacks.

Posted: May 19, 2018 5:18 AM

(CNN) -- Migraine sufferers across the United States have their eyes on a newly approved drug that's offering hope for reducing the frequency of monthly migraine attacks.

On Thursday, the US Food and Drug Administration approved Aimovig for the preventive treatment of migraines in adults with episodic or chronic migraines. Episodic migraine is when symptoms occur zero to 14 days each month; symptoms of chronic migraine occur 15 days or more a month.

Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, or CGRP, a molecule that is involved in migraine attacks. Aimovig targets that molecule's receptor in your body.

The treatment, administered through monthly self-injections, requires a prescription and could be available to patients within a week. Aimovig is expected to cost $575 monthly or $6,900 annually in the United States.

There are three other migraine treatments in this newly emerging class of drugs.

Those drugs target the CGRP molecule itself, instead of its receptor. They are experimental but, if approved, might be made available to patients as early as this fall for one and next year for the others, said Dr. Stewart Tepper, director of the Dartmouth Headache Center at Dartmouth-Hitchcock Medical Center in New Hampshire, who was a clinical investigator in the Aimovig trials.

"When CGRP is released, outside of the brain, it causes inflammation and blood vessel dilation -- the blood vessels get big -- and that combination of inflammation and blood vessels getting big is the pain of migraine," said Tepper, who is also a professor of neurology at the Geisel School of Medicine at Dartmouth College.

Migraine is three times more common in women than in men and affects more than 10% of people worldwide, the FDA noted. In the US, about 12% of the population gets migraine headaches.

What was found in clinical trials
The effectiveness of Aimovig was evaluated in three key clinical trials.

The first included 955 people with a history of episodic migraine. Over the course of six months, those who received the treatment experienced one or two fewer monthly migraine days, on average, compared with a placebo.

The second study included 577 patients with a history of episodic migraine. Over the course of three months, those who received Aimovig treatment experienced one fewer migraine day per month.

The third study evaluated 667 patients with a history of chronic migraine. Over the course of three months, patients treated with Aimovig experienced, on average, 2½ fewer monthly migraine days than those receiving a placebo.

"It may not get rid of all of them, but it really dramatically improves the frequency, severity and duration of the migraine attacks," Tepper said of the new treatment.

Patients "still will need to take something when they get a migraine attack, but this is the first designer medication to prevent migraine rather than treat as needed," he said.

In the clinical studies, the most common adverse side effects were pain at the injection site and constipation. The drug can be injected in the thigh, the abdomen or the outer area of the upper arm.

"The field is excited about a new drug that is specifically targeted for migraine mechanisms," said Dr. Teshamae Monteith, assistant professor of clinical neurology at the University of Miami and a member of the American Academy of Neurology, who was not involved in the development of the drug.

"Not only does the data show that it's effective for people who have what we call episodic migraine, but it's also effective for people who have chronic migraine," Monteith said.

"If you can imagine, a patient with chronic migraine has at least 15 days -- half the month -- with some type of headache, and eight days out of that month, it's what you would call a moderate to severe headache with associated symptoms, such as light sensitivity, sound sensitivity, some cognitive dysfunction, [gastrointestinal] symptoms and sometimes visual and motor symptoms," she said. "Patients can have fatigue, concentration impairment, neck stiffness and sometimes mood changes as well."

By Friday, Monteith was already receiving requests for prescriptions and questions about Aimovig from her patients, including Helene Good, who uses injections of Botox to treat her migraines.

'It's really exciting'
"I first heard about it when it showed up on my phone this morning as an article in my news, and I just happened to be on my way to see Dr. Monteith for my treatment today," Good said Friday.

"I read it to my spouse on the way over, and it's really exciting," said Good, a 63-year-old Miami resident who has had migraines since she was in her late teens.

"It's not like just having a bad headache. For me, it manifests in other ways," she said. "One side of my face droops, which sort of looks like I've had a mini stroke. I'm a pretty fast speaker, but my speech gets very slow."

When it comes to migraine treatment options, "you're always hoping and looking for hope," she said.

Treatment options for migraine sufferers typically depend on the frequency and severity of the migraine attacks. Patients who have episodic migraine usually rely on pain medications to treat the migraine pain. To avoid episodes, some patients may stay away from triggers, such as certain foods, lack of sleep or stress.

Before Aimovig, "the FDA-approved preventive medications for episodic migraine were only four. Two of them are beta blockers, anti-blood pressure medicines, and two of them are anti-epilepsy drugs," Tepper said.

"There was one FDA-approved treatment for chronic migraine, which was Botox," he said. For patients, "with our current preventive medicines, they have to take oral medicine every day, with the exception of Botox, which is given in 31 injections every 12 weeks."

Yet a problem with many of those other treatment options is that some are traditionally used for other disorders and have side effects, Monteith said.

"Not only are some of the drugs not effective for every patient, but then there's this issue with tolerability," she said. "Some of these drugs are not well-tolerated. In the right person, it's great, but certainly we need some other option."

Additionally, there are medical devices such as a FDA-approved nerve-stimulating "tiara" called Cefaly, another nerve-stimulating device called gammaCore and even an approach called transcranial magnetic stimulation. Some patients have turned to acupuncture for migraine therapy.

"As a headache specialist, there are a number of treatments that are available for our patients preventively for migraine, but many of them are associated with a lot of different side effects, and we've been waiting for the day when we can have a medication that specifically targets migraine and prevents it in this unique modality and is associated with few side effects," said Dr. Thomas Berk, headache neurologist at NYU Langone Health, who was not involved in the development of the new treatment.

"I've had a number of requests already from patients asking, is it possible to get it to them quickly? What are the ways of getting it, and the big question being, is my insurance going to cover it, which is a question that we don't really know particularly yet," he said. "Everyone's excited about it."

Terre Haute
Cloudy
52° wxIcon
Hi: 63° Lo: 52°
Feels Like: 52°
Robinson
Cloudy
51° wxIcon
Hi: 61° Lo: 51°
Feels Like: 51°
Indianapolis
Cloudy
52° wxIcon
Hi: 63° Lo: 53°
Feels Like: 52°
Rockville
Cloudy
51° wxIcon
Hi: 63° Lo: 51°
Feels Like: 51°
Casey
Cloudy
52° wxIcon
Hi: 56° Lo: 51°
Feels Like: 52°
Brazil
Cloudy
52° wxIcon
Hi: 63° Lo: 51°
Feels Like: 52°
Marshall
Cloudy
52° wxIcon
Hi: 58° Lo: 51°
Feels Like: 52°
Cloudy and Cool
WTHI Planner
WTHI Temps
WTHI Radar

WTHI Events

 

Illinois Coronavirus Cases

(Widget updates once daily at 7 p.m. CT)

Cases: 1675793

Reported Deaths: 27960
CountyCasesDeaths
Cook63468311202
DuPage1081271376
Will912621126
Lake800101085
Kane68370871
Winnebago41041560
Madison40087596
St. Clair36272596
McHenry34708329
Champaign26998197
Peoria26928368
Sangamon25754285
McLean23012218
Tazewell20647330
Rock Island18854361
Kankakee17910248
Kendall16203113
Macon15305250
LaSalle15030287
Vermilion14371199
Adams13156152
DeKalb12152133
Williamson12054174
Whiteside8297183
Jackson808694
Boone794383
Coles7888124
Ogle756887
Grundy738086
Franklin7330115
Knox7286169
Clinton7124102
Macoupin6951105
Marion6918143
Henry663777
Effingham660299
Jefferson6550143
Livingston597698
Stephenson584592
Woodford576892
Randolph5553100
Christian533682
Fulton526976
Monroe5246103
Morgan5076100
Logan495074
Montgomery491681
Lee478660
Bureau442691
Saline433869
Perry433275
Fayette430664
Iroquois421577
McDonough373761
Shelby347748
Jersey335653
Lawrence332533
Crawford332430
Douglas327337
Union306548
Wayne304063
White279833
Richland279557
Hancock274135
Cass266230
Clark265740
Pike264558
Clay258754
Edgar258049
Bond256925
Warren244066
Ford243959
Carroll236438
Moultrie234533
Johnson228131
Wabash217319
Jo Daviess216029
Massac215550
Mason214252
Washington212228
De Witt205530
Greene205340
Mercer204336
Piatt201614
Cumberland190026
Menard172213
Jasper161221
Marshall141321
Hamilton134022
Schuyler107710
Brown106510
Edwards104018
Pulaski103911
Stark81628
Gallatin7878
Alexander71912
Scott7136
Henderson70314
Calhoun6922
Hardin60116
Putnam5654
Pope5526
Unassigned1702433
Out of IL160

Indiana Coronavirus Cases

(Widget updates once daily at 8 p.m. ET)

Cases: 1003647

Reported Deaths: 16423
CountyCasesDeaths
Marion1351072116
Lake661851159
Allen57674800
Hamilton46217464
St. Joseph44210611
Elkhart35807508
Vanderburgh32162480
Tippecanoe27859258
Johnson25007444
Hendricks23795357
Porter22856365
Madison18694408
Clark18505252
Vigo17393303
Monroe15218199
LaPorte15101250
Delaware15024261
Howard14681289
Kosciusko12260147
Hancock11682175
Bartholomew11548180
Warrick11270189
Floyd11059214
Wayne10946253
Grant10019219
Morgan9438176
Boone8891116
Dubois8249131
Dearborn819893
Henry8174152
Noble8003106
Marshall7891135
Cass7519121
Lawrence7433171
Shelby7171119
Jackson695889
Gibson6567115
Harrison646691
Huntington636899
Knox6360106
DeKalb628699
Montgomery6229109
Miami591498
Putnam577678
Clinton572171
Whitley563455
Steuben558976
Wabash5309103
Jasper527879
Jefferson509297
Ripley498686
Adams479775
Daviess4653114
Scott438473
Greene423596
Wells422588
Clay421360
White417364
Decatur4152102
Fayette405787
Jennings385961
Posey375844
Washington356150
LaGrange356078
Randolph343499
Spencer338743
Fountain333860
Sullivan327852
Starke315570
Owen313970
Fulton309167
Orange292663
Jay283445
Franklin265143
Perry264852
Rush260832
Carroll260633
Vermillion257254
Parke230426
Pike228443
Tipton227259
Blackford191841
Pulaski183157
Crawford159023
Newton156848
Benton150217
Brown145747
Martin138019
Switzerland134811
Warren120816
Union107016
Ohio84213
Unassigned0540